Your browser is no longer supported. Please, upgrade your browser.
Settings
ARRY Array BioPharma Inc. daily Stock Chart
ARRY [NASD]
Array BioPharma Inc.
Index- P/E- EPS (ttm)-0.67 Insider Own0.10% Shs Outstand165.80M Perf Week0.53%
Market Cap1.90B Forward P/E- EPS next Y-0.73 Insider Trans-93.76% Shs Float165.80M Perf Month3.44%
Income-99.60M PEG- EPS next Q-0.18 Inst Own99.00% Short Float10.11% Perf Quarter44.32%
Sales170.00M P/S11.15 EPS this Y-12.30% Inst Trans7.43% Short Ratio4.19 Perf Half Y260.57%
Book/sh0.31 P/B36.87 EPS next Y0.00% ROA-49.50% Target Price12.50 Perf Year339.62%
Cash/sh1.29 P/C8.86 EPS next 5Y10.00% ROE754.40% 52W Range2.50 - 13.40 Perf YTD30.03%
Dividend- P/FCF- EPS past 5Y8.60% ROI-108.50% 52W High-14.70% Beta2.10
Dividend %- Quick Ratio4.10 Sales past 5Y13.90% Gross Margin82.90% 52W Low357.20% ATR0.61
Employees177 Current Ratio4.10 Sales Q/Q25.70% Oper. Margin-51.60% RSI (14)56.21 Volatility5.79% 5.74%
OptionableYes Debt/Eq2.46 EPS Q/Q18.10% Profit Margin-58.60% Rel Volume1.02 Prev Close10.56
ShortableYes LT Debt/Eq2.26 EarningsFeb 09 BMO Payout- Avg Volume4.01M Price11.43
Recom1.90 SMA202.87% SMA5012.14% SMA20086.01% Volume4,098,613 Change8.24%
Feb-03-17Reiterated Stifel Buy $8 → $13
Feb-03-17Downgrade JP Morgan Overweight → Neutral
Jan-30-17Downgrade Leerink Partners Outperform → Mkt Perform
Sep-26-16Reiterated Piper Jaffray Overweight $7 → $10
Sep-26-16Reiterated Leerink Partners Outperform $6 → $9
Jan-26-15Reiterated Stifel Buy $6 → $9
Aug-09-13Reiterated Stifel Buy $7 → $8
Jul-23-10Upgrade UBS Neutral → Buy $4.25
Apr-22-10Downgrade UBS Buy → Neutral
Nov-05-09Upgrade UBS Neutral → Buy
Sep-08-09Downgrade UBS Buy → Neutral
Sep-04-09Downgrade Robert W. Baird Outperform → Neutral $10 → $3
Sep-04-09Downgrade Leerink Swann Outperform → Mkt Perform $6 → $2
Sep-04-09Downgrade Boenning & Scattergood Outperform → Neutral
Jun-17-09Initiated Boenning & Scattergood Outperform $6
May-07-08Reiterated Rodman & Renshaw Mkt Outperform $18 → $15
Feb-07-08Initiated William Blair Outperform
Dec-20-07Reiterated Collins Stewart Buy $17 → $16
Dec-04-07Initiated Morgan Joseph Buy $16
Nov-07-07Reiterated Collins Stewart Buy $20 → $17
Feb-27-17 07:39PM  Cramer's lightning round: The only Chinese stock I will recommend at CNBC +8.24%
Feb-22-17 02:09PM  How High Can Array BioPharma Inc. Stock Go? at Motley Fool
Feb-17-17 09:30AM  Biotech Industry Positioned for a Potential Breakout in 2017: Today's Reports on Array Biopharma and Opko Health Accesswire
Feb-15-17 09:48AM  Want to Get In on Biotech? Check Out These 3 Stocks at Motley Fool
Feb-14-17 02:27PM  ETFs with exposure to Array BioPharma, Inc. : February 14, 2017
01:04PM  ARRAY BIOPHARMA INC Financials
Feb-13-17 10:20AM  Array BioPharma, Inc. :ARRY-US: Earnings Analysis: Q2, 2017 By the Numbers : February 13, 2017
Feb-10-17 08:22AM  Is Array BioPharma the Best Clinical-Stage Biotech Stock to Buy in 2017? at Motley Fool
Feb-09-17 04:33PM  Here's Why Array Biopharma Inc Stock Is Climbing Again Today at Motley Fool +17.38%
03:28PM  Edited Transcript of ARRY earnings conference call or presentation 9-Feb-17 2:00pm GMT
12:22PM  Array BioPharma 4Q Loss 14c/Share Beats Street at Investopedia
09:00AM  Array Biopharma Inc Earnings Call scheduled for 9:00 am ET today
08:47AM  Array BioPharma reports 2Q loss
08:33AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib
08:30AM  Array BioPharma Reports Financial Results For The Second Quarter Of Fiscal 2017 PR Newswire
08:14AM  ARRAY BIOPHARMA INC Files SEC form 10-Q, Quarterly Report
07:07AM  Q2 2017 Array Biopharma Inc Earnings Release - Before Market Open
Feb-08-17 09:00AM  Array BioPharma To Present At The Leerink Partners Annual Global Healthcare Conference PR Newswire
Feb-03-17 08:19AM  Analysts' Actions -- Eaton, Ford, Altria, Ralph Lauren and More
07:10AM  Array Biopharma downgraded by JP Morgan
Feb-02-17 04:22PM  Why Array BioPharma Soared 23.7% in January at Motley Fool
02:55PM  Array BioPharma to Report Financial Results for the Second Quarter of Fiscal 2017 on February 9, 2017 PR Newswire
Jan-30-17 04:32PM  I-O Players Incyte, Roche Squeeze Array's Melanoma Market: Leerink -5.18%
08:17AM  Analysts' Actions -- Air Products, Disney, Colgate-Palmolive, Noble and More
Jan-21-17 08:24AM  3 Stocks That Tripled at Motley Fool
Jan-20-17 07:22PM  Cramer says take off half and play with the house's money on this stock at CNBC
04:38AM  Will Array BioPharma (ARRY) Continue to Surge Higher?
Jan-18-17 07:41PM  Energy And Biotech Momentum Stocks To Watch at Forbes
Jan-16-17 09:30AM  Zacks Investment Ideas feature highlights: Array BioPharma, BHP Billition, MSC Industrial Direct, Rio Tinto and Vantiv
08:30AM  Array BioPharma (ARRY) Jumps: Stock Adds 7.5% in Session
Jan-10-17 12:21PM  After ARIAD's Acquisition, These 3 Cancer Drug Stocks Could Be Next at Motley Fool
Jan-09-17 10:26AM  Why Array BioPharma Inc Stock Surged 108.3% in 2016 at Motley Fool +5.15%
Jan-03-17 09:00AM  Array BioPharma To Present At The Annual J.P. Morgan Healthcare Conference PR Newswire
Dec-23-16 04:04PM  ARRAY BIOPHARMA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definit
Dec-11-16 09:39AM  Is Array Biopharma Inc (ARRY) A Good Stock To Buy? at Insider Monkey
Dec-03-16 03:33PM  Why Array BioPharma Rose 32.5% in November at Motley Fool
Nov-22-16 10:00AM  Array BioPharma To Present At The Piper Jaffray Annual Healthcare Conference PR Newswire
Nov-15-16 12:27PM  Is Redmile Group Right to Bet on Array Biopharma Inc (ARRY), Amicus Therapeutics, Inc. (FOLD) & Two Other Stocks? at Insider Monkey
Nov-10-16 11:07AM  Array Biopharma Inc (ARRY) Updates On COLUMBUS Phase 3 And Its Impressive at Insider Monkey
03:06AM  Array Biopharma Inc (ARRY) Stock: Gaining Big On Clinical Data at Insider Monkey
Nov-09-16 10:19AM  The Market Offers Some Opportunities but They're Disappearing Fast +7.43%
10:17AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
10:00AM  COLUMBUS Phase 3 Study Results in BRAF-Mutant Melanoma Presented at Society for Melanoma Research Annual Congress PR Newswire
Nov-08-16 02:00PM  Array BioPharma To Present At The Stifel 2016 Healthcare And Jefferies 2016 Global Healthcare Conferences PR Newswire
Nov-06-16 10:15AM  7 Analyst Stocks Under $10 for Massive Upside Projections at 24/7 Wall St.
Nov-04-16 08:50AM  Top Analyst Upgrades and Downgrades: Agrium, Array BioPharma, Encana, GoPro, 3D Systems and More at 24/7 Wall St. +8.92%
Nov-03-16 08:38AM  ARRAY BIOPHARMA INC Files SEC form 10-Q, Quarterly Report -7.88%
Nov-01-16 04:01PM  Edited Transcript of ARRY earnings conference call or presentation 1-Nov-16 1:00pm GMT +7.19%
09:00AM  Array Biopharma Inc Earnings Call scheduled for 9:00 am ET today
08:30AM  Array BioPharma reports 1Q loss
08:03AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib
08:00AM  Array BioPharma Reports Financial Results For The First Quarter Of Fiscal 2017 PR Newswire
07:07AM  Q1 2017 Array Biopharma Inc Earnings Release - Before Market Open
Oct-31-16 02:09PM  Take a Chill Pill: If Clinton Wins, Drug-Price Controls Aren't Guaranteed
11:08AM  Research Reports on Biotech Equities -- Mast Therapeutics, Array BioPharma, Galena Biopharma, and Clovis Oncology PR Newswire
Oct-25-16 04:31PM  Array BioPharma And Pierre Fabre To Present Phase 3 COLUMBUS Trial At Society For Melanoma Research Annual Congress PR Newswire
11:00AM  Array BioPharma To Report Financial Results For The First Quarter Of Fiscal 2017 On November 1, 2016 PR Newswire
Oct-14-16 10:10AM  Array BioPharma (ARRY) is in Overbought Territory: What's Next?
Oct-11-16 10:05AM  ETFs with exposure to Array BioPharma, Inc. : October 11, 2016
Oct-10-16 11:21AM  Why Array BioPharma Skyrocketed 91% in September at Motley Fool
Oct-09-16 11:13AM  3 Cancer Drugs That Could Get an FDA OK Next Year at Motley Fool
Oct-03-16 10:12AM  Array BioPharma Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares PR Newswire
08:39AM  6 Best Performing Drug Stocks of September
Oct-02-16 10:05AM  Top 6 Biopharma Gainers of the Past Week at 24/7 Wall St.
Sep-29-16 11:12PM  Array Announces $100M Public Offering (ARRY) at Investopedia
Sep-28-16 05:55PM  Array BioPharma Reports Positive Results (ARRY) at Investopedia
04:50PM  ARRAY BIOPHARMA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statement
09:59AM  Why Wells Fargo, Select Comfort, Array Biopharma, American Express, and More Are Trending at Insider Monkey
Sep-27-16 09:23PM  Array BioPharma Announces Pricing of Public Offering of Common Stock PR Newswire
06:20PM  3 Reasons to Buy Array Biopharma at Motley Fool
04:27PM  Array BioPharma Announces Proposed Public Offering of Common Stock PR Newswire
02:01PM  ProNAi Therapeutics Inc. (DNAI), Ballard Power Systems Inc. (USA) (BLDP) & More: Major Hype Surrounding These Stocks Today at Insider Monkey
12:50PM  Array BioPharma (ARRY) Stock Up, JPMorgan Raises Price Target on Drug Success
11:49AM  Momentum Carries Lululemon Lower, Pushes Biotech Names Higher at Forbes
09:51AM  ETFs with exposure to Array BioPharma, Inc. : September 27, 2016
09:42AM  Array (ARRY) Hits 52-Week High on Positive Phase III Data
08:45AM  Top Analyst Upgrades and Downgrades: CBOE, Comcast, GW Pharma, Hormel, Vonage, Wells Fargo and Many More at 24/7 Wall St.
Sep-26-16 10:58PM  Futures Swing Into Positive Territory During Debate, Asia Lower +81.10%
06:03PM  Why Array BioPharma, Chemtura, and GW Pharmaceuticals Jumped Today at Motley Fool
01:35PM  5 Big-Volume Stocks You Should Stay Away From -- Plus 2 to Buy
12:49PM  Why Investors Are Buzzing About Yum, Twitter, GM, RetailMeNot, and Array Biopharma Today at Insider Monkey
12:11PM  Why Array BioPharma Inc Is Surging Today at Motley Fool
12:10PM  Array Biopharma Shares Soar on Melanoma Trials Early Results
11:50AM  Array BioPharma (ARRY) Stock Soars on Drug Success, Piper Jaffray Ups Price Target
10:15AM  4 Biopharma Companies Moving on Monday Ahead of the Presidential Debate at 24/7 Wall St.
09:20AM  Stocks to Watch: Chemtura, Deutsche Bank, Array BioPharma at The Wall Street Journal
09:00AM  Array Biopharma Inc Conference Call regarding Phase 3 COLUMBUS study scheduled for 9:00 am ET today
07:02AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
07:00AM  Array BioPharma and Pierre Fabre Announce COLUMBUS Phase 3 Study of Encorafenib plus Binimetinib For BRAF-Mutant Melanoma Met Primary Endpoint PR Newswire
Sep-24-16 12:09PM  3 Biotechs That Could Be M&A Targets at Motley Fool
Sep-21-16 01:38PM  5 Stocks Insiders Love Right Now
11:23AM  Array BioPharma, Inc. Value Analysis (NASDAQ:ARRY) : September 21, 2016
Sep-20-16 08:13AM  Array BioPharma, Inc. breached its 50 day moving average in a Bullish Manner : ARRY-US : September 20, 2016
Sep-18-16 10:15AM  10 Analyst Stock Picks Under $10 for Massive Upside at 24/7 Wall St.
Sep-14-16 08:25PM  Array Secures SPA Agreement With FDA for Colorectal Cancer Trial (ARRY) at Investopedia
12:08PM  Why Sarepta, Glu Mobile, Harmony Gold and 2 Other Stocks Are On The Move Today at Insider Monkey
08:20AM  Key FDA Decisions and Trial Results Coming in the Next 2 Months at 24/7 Wall St.
07:33AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
07:30AM  Array BioPharma Announces Phase 3 BEACON CRC SPA Agreement with FDA PR Newswire
Sep-12-16 01:55PM  Why Array Biopharma May Become a Winner (ARRY) at Investopedia +5.56%
Array BioPharma Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs to treat patients with cancer in North America, Europe, and the Asia Pacific. The company's drugs in Phase III clinical trials include Binimetinib, Encorafenib, and Selumetinib for the treatment of cancer, as well as ASC08/Danoprevir, a protease inhibitor for hepatitis C virus. Its drug candidates in Phase II clinical trials comprise Filanesib, a kinesin spindle protein inhibitor for multiple myeloma; ARRY-797, a p38 inhibitor for Lamin A/C-related dilated cardiomyopathy; ASLAN001/Varlitinib, a pan-HER2 inhibitor for gastric or breast cancer; Ipatasertib/GDC-0068, an AKT inhibitor for cancer; Motolimod/VTX-2337, a toll-like receptor for cancer; Prexasertib/LY2606368, a chk-1 inhibitor for cancer; LOXO-101, a PanTrk inhibitor for cancer; and ONT-380/ARRY-380, an HER2 inhibitor for breast cancer. The company's Phase I drugs include GDC-0994, an ERK inhibitor for cancer; and ARRY-382, a CSF1R inhibitor for cancer, as well as Phase Ib drug candidate comprises GDC-0575, a chk-1 inhibitor for cancer. Array BioPharma Inc. was founded in 1998 and is headquartered in Boulder, Colorado.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
VAN LUNSEN GIL JDirectorOct 29Option Exercise5.835,00029,15010,260Oct 31 07:46 PM
BAUM CHARLES MDirectorOct 29Option Exercise5.835,00029,1505,000Oct 31 07:15 PM
Fyfe Gwen A.DirectorOct 29Option Exercise5.835,00029,1505,000Oct 31 07:15 PM
LEFKOFF KYLEDirectorOct 29Option Exercise5.835,00029,1508,585Oct 31 07:15 PM
Orwin John ADirectorOct 29Option Exercise5.835,00029,1505,000Oct 31 07:15 PM
Redmile Group, LLC10% OwnerSep 28Sale6.362,492,57815,852,79616,658,072Sep 30 03:55 PM
Sandor VictorChief Medical OfficerSep 22Option Exercise3.6995,890353,834200,733Sep 23 07:52 PM
Redmile Group, LLC10% OwnerSep 15Buy3.5028,00098,00019,150,650Sep 16 04:00 PM
Redmile Group, LLC10% OwnerSep 15Sale3.547,30025,84219,122,650Sep 16 04:00 PM
Redmile Group, LLC10% OwnerSep 14Buy3.51372,0001,305,72019,129,950Sep 16 04:00 PM
Redmile Group, LLC10% OwnerSep 14Sale3.50392,7001,374,45018,757,950Sep 16 04:00 PM